Sun Pharma India Plant Undergoing U.S. Inspection, Source Says
This article was originally published in PharmAsia News
Executive Summary
U.S. FDA inspectors reportedly have begun a surprise inspection of Sun Pharmaceutical Industries plant in India that was the subject of a recent recalls of drugs exported to the U.S.